Reference
1
Fatima
Amanat,
Kris
M White,
Lisa
Miorin, et al. An In Vitro Microneutralization Assay for SARS-CoV-2
Serology and Drug Screening. Curr Protoc Microbiol 2020 Sep;58(1):e108.
2
Jun-Gyu
Park,
Fatai
S. Oladunni,
Kevin
Chiem, et al. Rapid in vitro assays for screening neutralizing
antibodies and antivirals against SARS-CoV-2.
J Virol
Methods. 2021 Jan;287:113995.
3
Zhenhao
Fang,
Lei
Peng,
Renata
Filler, et al. Omicron-specific mRNA vaccination alone and as a
heterologous booster against SARS-CoV-2. Nat Commun.2022 Jun
6;13(1):3250.
4
Bin
Ju,
Qi
Zhang,
Jiwan
Ge, et al Human neutralizing antibodies elicited by SARS-CoV-2
infection. Nature 2020,584, 115-119.
5 Heli Harvala, Matthew L. Robb, Nick Watkins, Convalescent plasma
therapy for the treatment of patients with COVID-19: Assessment of
methods available for antibody detection and their correlation with
neutralising antibody levels Transfusion Medicine.2021;31:167-175.
6 Weidner L, Gänsdorfer S, Unterweger S, et al. Quantification of
SARS‐CoV‐2 antibodies with eight commercially available immunoassays. J
Clin Virol.2020;129:104540.
7 Llipsy Santiago, Iratxe Uranga-Murillo 1, Maykel Arias 2, Andrés
Manuel González-Ramírez, et al. Determination of the Concentration of
IgG against the Spike Receptor-Binding Domain That Predicts the Viral
Neutralizing Activity of Convalescent Plasma and Serum against
SARS-CoV-2 Biology 2021, 10, 208.
8 Nie J,Li Q, Wu J, et al. Establishment and validation of a pseudovirus
neutralization assay for SARS-CoV-2. Emerg Microbes
Infect.2020;9:680-686.
9 Srijan Chatterjee, Manojit Bhattacharya, Sagnik Nag, et al. A Detailed
Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and
Pathophysiology, Clinical Characteristics, Immunological Landscape,
Immune Escape, and Therapies. Viruses.2023 Jan 5;15(1):167.
10
Aekkachai
Tuekprakhon ,
Rungtiwa
Nutalai, et
al.Aiste
Dijokaite-Guraliuc, Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5
from vaccine and BA.1 serum.
Cell. 2022
Jul 7; 185(14): 2422-2433.e13.
11 Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of
SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. Lancet
2022; 399: 234-36.
12 Pajon R, Doria-Rose NA, Shen X, et al. SARS-CoV-2 omicron variant
neutralization after mRNA-1273 booster vaccination. N Engl J Med 2022;
386: 1088-91.
13 Dolscheid-Pommerich R, Bartok E, Renn M, Kümmerer BM, et al.
Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and
neutralization activity. J Med Virol. 2022 Jan;94(1):388-392.